Story

The Full Story

Blue Moon Group Holdings listed in December 2020 as China's dominant laundry detergent brand, raising HK$11 billion in one of Hong Kong's largest consumer staples IPOs and reporting HK$1.3 billion in profit that year. Over the following five years, every profitability metric deteriorated — net income collapsed from HK$1.3 billion to a HK$749 million loss — while management reframed each year's decline first as temporary headwinds, then as deliberate "strategic investment." The cash pile shrank from HK$10.9 billion to HK$3.7 billion. The stock fell 76% from its HK$13.16 IPO price. In FY2025 the loss narrowed 56%, but after five consecutive years of broken profitability promises, the turnaround remains more narrative than proof.

The Narrative Arc

The story has five distinct phases:

Phase 1 — IPO Peak (FY2020): Blue Moon listed at HK$13.16 per share, backed by a 64.5% gross margin, HK$1.3 billion profit, and #1 brand power rankings held for over a decade. The business looked like a quality consumer franchise.

Phase 2 — Slow Bleed (FY2021-FY2022): Profit fell 22% then another 40%. Management blamed COVID disruptions, raw material cost spikes, and RMB depreciation. Selling expenses crept from 29% to 33% of revenue. The company introduced non-HKFRS "adjusted" metrics in FY2022 to strip out FX losses — then quietly dropped them the following year.

Phase 3 — The Crack (FY2023): Revenue declined for the first time (-7.8% in HK$ terms). Selling expenses surged 22% even as revenue shrank, pushing S&D to 44% of revenue. Profit halved again to HK$325 million. The post-COVID recovery narrative evaporated.

Phase 4 — The Investment Bet (FY2024): Management launched the Zhizun concentrated detergent line and poured money into e-commerce and "knowledge-based marketing." Revenue jumped 17% but selling expenses exploded 56% to HK$5.0 billion — 59% of revenue. The result: the worst loss in company history at HK$749 million. Management called it "strategic investment."

Phase 5 — Claiming the Turn (FY2025): Revenue was flat (-1.7%) but S&D fell 12% and G&A fell 13%. The loss narrowed 56% to HK$329 million. Management declared "substantial progress in strategic adjustment." But cash fell another HK$1.6 billion to HK$3.7 billion — and the company still paid HK$585 million in dividends while losing money.

What Management Emphasized — and Then Stopped Emphasizing

What disappeared: COVID impact and O2O platform leadership — once headline themes — vanished entirely by FY2024. Neither was replaced with a retrospective on outcomes; they were simply no longer mentioned.

What appeared from nowhere: "Zhizun concentrated detergent" and "knowledge-based marketing" went from zero mentions to the dominant narrative in a single year (FY2024). The word "strategic" — previously rare — became the central framing device for all spending decisions.

What quietly intensified: "Cost optimization" appeared for the first time in FY2025 and immediately became the top theme. This is the clearest signal that the FY2024 spending spree was not entirely planned — if it were, management would not need to rebrand discipline as a new strategy.

The chart above reveals the core problem: gross margins recovered from the FY2021 raw-material shock and stabilized near 60%, but selling and distribution expenses doubled as a share of revenue — from 29% to 59% — swallowing every margin dollar and more. This is not a gross profit problem. It is a spending problem.

The channel mix tells its own story. Key accounts — hypermarkets and supermarkets that once contributed 14% of revenue — collapsed to under 4% by FY2024. Management attributed this to "change of consumer habits," but earlier disclosures reveal the real driver: the company deliberately reduced sales to credit-based key accounts to manage receivables risk after impairment provisions surged to HK$88 million in FY2023. The shift to online (now 59% of revenue) is where the S&D money went.

Risk Evolution

The risk profile has fundamentally changed. At the IPO, the risks were external — raw materials, COVID, FX. By FY2024-FY2025, the dominant risks are self-inflicted: uncontrolled selling expenses, a deteriorating cash position, and no clear path back to profitability.

Risks that faded: Raw material costs and COVID disruption are no longer relevant. FX risk was defused in 2022 when the company converted offshore RMB deposits to USD.

Risks that intensified: S&D cost inflation is the defining risk. The company nearly doubled selling expenses as a share of revenue in three years. Cash consumption has become the second-largest concern — HK$7.2 billion in cash has disappeared in five years, and the remaining HK$3.7 billion gives the company roughly 2-3 years of runway at current burn rates if profitability does not improve.

Risks that were solved, then replaced: Credit/receivables risk peaked in FY2023 (HK$88 million impairment) and was resolved by abandoning credit-based key accounts. But this fix created a new dependency on expensive e-commerce channels, which in turn drove the S&D explosion.

How They Handled Bad News

Management followed a consistent playbook across five years of declining profitability:

Pattern 1 — External attribution. Every miss was pinned on something outside management's control. In FY2021, it was COVID and raw materials. In FY2022, it was RMB depreciation. In FY2023, it was "normalization of inventory levels" post-pandemic. In FY2024, the frame shifted: the loss was not a miss but a deliberate choice.

Pattern 2 — Metric shopping. When FY2022 profit fell 40%, management introduced non-HKFRS "adjusted" metrics to strip out FX losses, presenting adjusted EBITDA of HK$1.26 billion instead of reported profit of HK$611 million. When FX impact faded in FY2023, the non-HKFRS measures were quietly retired: "the Group has no longer disclosed the non-HKFRS measures."

Pattern 3 — Reframing cost overruns as strategy. The FY2024 selling expense increase of 56% — from HK$3.2 billion to HK$5.0 billion — was not described as a cost control failure but as "strategic investments" that "will contribute to the Group's long-term sales growth." Revenue then fell 1.7% the following year.

Pattern 4 — Dividends as distraction. The company paid HK$0.10 per share (HK$585 million total) for FY2025 and HK$0.06 per share for FY2024 — both years in which it recorded losses. These dividends are funded from the IPO cash pile, not earnings. The "stable shareholder returns" narrative papers over the fact that the business is consuming its own capital.

Guidance Track Record

Why 3 out of 10: Management promised profitability improvement every year from FY2021 onwards. They missed every single time until FY2025, when they achieved a partial win (loss narrowed but the business is still unprofitable). The non-HKFRS measure episode in FY2022 — introduced to manage appearances, then quietly dropped — further erodes trust. The "strategic investment" reframe in FY2024 may ultimately prove correct, but it came without warning and without a clear timeline for return on investment. The most damaging pattern is the gap between what was promised ("improve financial conditions") and what was delivered (five years of consecutive deterioration from HK$1.3 billion profit to HK$329 million loss).

One positive: the FY2025 loss reduction of 56% does match the early guidance issued in January 2026 ("at least halved"). This is the first time management has set an expectation and met it.

What the Story Is Now

The current narrative is: Blue Moon is China's #1 laundry detergent brand (15 consecutive years of market leadership), now transitioning to a concentrated "Zhizun" product line that commands premium positioning. FY2024 was the peak investment year; FY2025 showed the inflection — costs are being optimized, the loss is narrowing, and the brand is stronger than ever.

What has been de-risked: Raw material costs have stabilized. Credit risk from key accounts has been eliminated (by abandoning the channel). The FX exposure was resolved. Employee headcount has been rationalized from 9,025 to 6,514. FY2025 proved that costs can come down.

What still looks stretched: The company has not been profitable since FY2023. Selling expenses at 53% of revenue remain extraordinarily high for a consumer staples business. Cash of HK$3.7 billion is declining at HK$1.5-2.0 billion per year. The dividend (HK$585 million in FY2025) is being paid from reserves, not earnings. Of the HK$11 billion IPO proceeds, HK$10.4 billion has been spent — with HK$2.6 billion going to "brand awareness and sales network" in 2025 alone.

What the reader should believe: The brand power is real — 15 years at #1 is not manufactured. The concentrated detergent shift has industry logic. Cost optimization in FY2025 was genuine, not just an accounting trick.

What the reader should discount: Management's timeline for profitability. Every prior promise was broken. The "strategic investment" framing was applied retroactively. Dividends paid from reserves should not be confused with shareholder value creation. And the most important question remains unanswered: can this business earn money selling laundry detergent at 53% S&D costs, or is it permanently trapped in a promotional arms race on Chinese e-commerce platforms?